Senior insider sale
Chief Medical Officer at UROGEN PHARMA LTD. — senior position signals high conviction
$3.64M
80.68K shares
What this filing means
SCHOENBERG MARK plans to sell 80.68K shares of UROGEN PHARMA LTD. valued at approximately $3.64M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/20/2026ACC: 0001000275-26-000100
Officer· Chief Medical Officer
Since Jan 2019
80.68K
Shares to sell
$3.64M
Approx. market value
60.68K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
N/A
1/27/2023
60.68KTotal acquired60.68K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/27/2023 | STOCK OPTION EXERCISE N/A | 60.68K | — |
| Total | 60.68K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
10K
Market value
$400.0K
7/9/2026
—Completed
Units to sell
10K
Market value
$350.1K
6/22/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
60.68K
Market value
$2.89M
8/20/2026
Total
Units
80.68K
Value
$3.64M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/9/2026 | 10K | $400.0K | — | Completed |
6/22/2026 | 10K | $350.1K | — | Completed |
| Planned — Approximate Date | ||||
8/20/2026 | 60.68K | $2.89M | NASDAQ | Planned |
| Total | 80.68K | $3.64M | ||